[
    [
        {
            "time": "2023-10-05",
            "original_text": "甘李药业胶质瘤创新药物获欧洲药品管理局孤儿药资格认定",
            "features": {
                "keywords": [
                    "甘李药业",
                    "胶质瘤",
                    "创新药物",
                    "欧洲药品管理局",
                    "孤儿药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "甘李药业胶质瘤创新药物获欧洲药品管理局孤儿药资格认定",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-06",
            "original_text": "甘李药业在研药物获EMA孤儿药资格认定",
            "features": {
                "keywords": [
                    "甘李药业",
                    "在研药物",
                    "EMA",
                    "孤儿药"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "甘李药业在研药物获EMA孤儿药资格认定",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-07",
            "original_text": "高瓴资本概念股普遍调整，良品铺子、甘李、金域、广联达、公牛跌幅居前",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "甘李",
                    "调整",
                    "跌幅"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "消费",
                    "科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本概念股普遍调整，良品铺子、甘李、金域、广联达、公牛跌幅居前",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-08",
            "original_text": "每日“药”闻|甘李药业创新药获欧盟孤儿药认定；礼来JAK抑制剂新适应症审查推迟",
            "features": {
                "keywords": [
                    "甘李药业",
                    "创新药",
                    "欧盟",
                    "孤儿药",
                    "礼来",
                    "JAK抑制剂"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "每日“药”闻|甘李药业创新药获欧盟孤儿药认定；礼来JAK抑制剂新适应症审查推迟",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-09",
            "original_text": "甘李药业CDK4/6抑制剂获欧盟孤儿药资格，治疗胶质母细胞瘤",
            "features": {
                "keywords": [
                    "甘李药业",
                    "CDK4/6抑制剂",
                    "欧盟",
                    "孤儿药",
                    "胶质母细胞瘤"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "甘李药业CDK4/6抑制剂获欧盟孤儿药资格，治疗胶质母细胞瘤",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]